Revision history of "Support for R & D processes in the company Private Medical Practice Paweł Lisewski by purchasing the necessary R & D infrastructure together with adaptation work to establish a clinical trial centre." (Q97834)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 October 2024

  • curprev 16:1916:19, 13 October 2024DG Regio talk contribs 95,814 bytes −4 Changed label, description and/or aliases in pt
  • curprev 16:1916:19, 13 October 2024DG Regio talk contribs 95,818 bytes +117 Set a claim value: summary (P836): O investimento consiste na criação de um centro de ensaios clínicos envolvendo doentes, no qual, acima de tudo, serão realizados ensaios clínicos para confirmar o funcionamento de novas substâncias ainda não registadas destinadas a tornarem-se medicamentos para doenças incuráveis, progressivas ou da civilização (fases II e III dos ensaios clínicos). Durante 5 anos, a empresa concentrou-se principalmente na pesquisa sobre doenças neurológicas. Por ou...

20 March 2024

15 January 2024

13 December 2023

10 June 2023

24 May 2023

2 March 2023

  • curprev 23:1123:11, 2 March 2023DG Regio talk contribs 92,531 bytes −1,030 Changed label, description and/or aliases in it, da, sk, el, fi, ro, de, cs, bg, lv, sv, ga, fr, lt, es, hu, pt, et, sl, nl, mt, hr, and other parts

27 October 2022

26 October 2022

21 October 2022

26 July 2022

  • curprev 09:3609:36, 26 July 2022DG Regio talk contribs 91,453 bytes +60,019 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

20 January 2022

16 January 2022

16 December 2021

7 December 2021

1 December 2021

  • curprev 06:4306:43, 1 December 2021DG Regio talk contribs 18,031 bytes +3,186 Created claim: summary (P836): L’investissement consiste en la création d’un centre d’essais cliniques impliquant des patients, dans lequel des essais cliniques seront menés principalement pour confirmer les effets de nouvelles substances non enregistrées destinées à devenir des médicaments pour des maladies incurables, progressives ou civilisées (phases II et III des essais cliniques). Depuis 5 ans, l’entreprise se concentre principalement sur la recherche sur les troubles n...
  • curprev 06:4306:43, 1 December 2021DG Regio talk contribs 14,845 bytes +317 Changed label, description and/or aliases in fr: translated_label

29 October 2020

15 October 2020

  • curprev 22:0822:08, 15 October 2020DG Regio talk contribs 14,968 bytes +260 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 22:0822:08, 15 October 2020DG Regio talk contribs 14,708 bytes −245 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 22:0822:08, 15 October 2020DG Regio talk contribs 14,953 bytes +2,949 Created claim: summary (P836): The investment consists of the creation of a clinical trial centre involving patients, in which, above all, clinical trials will be conducted to confirm the operation of new, still unregistered substances intended to become drugs for incurable, progressive or civilisation diseases (phase II and III of clinical trials). For 5 years, the company has focused mainly on research on neurological diseases. On the other hand, the new centre of research...
  • curprev 22:0822:08, 15 October 2020DG Regio talk contribs 12,004 bytes −2,322 Removed claim: summary (P836): The investment consists of the setting up of a clinical trial site with the involvement of patients, which will primarily carry out clinical trials for the purpose of proving the operation of new, yet unregistered substances intended to become medicines for incurable, progressive or civilisational diseases (Phase II and III clinical trials). The company has been focusing on neurological studies for 5 years. On the other hand, the new research...

23 September 2020

22 June 2020

10 June 2020

7 June 2020

26 March 2020

6 March 2020

  • curprev 07:3007:30, 6 March 2020DG Regio talk contribs 13,039 bytes +2,322 Created claim: summary (P836): The investment consists of the setting up of a clinical trial site with the involvement of patients, which will primarily carry out clinical trials for the purpose of proving the operation of new, yet unregistered substances intended to become medicines for incurable, progressive or civilisational diseases (Phase II and III clinical trials). The company has been focusing on neurological studies for 5 years. On the other hand, the new research ce...

24 February 2020

18 February 2020

31 January 2020

14 January 2020